Dose-finding trial of a combined regsimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An italian oncology group for clinical research (GOIRC) study

Sebastiano Buti, Silvia Lazzarelli, Matteo Dalla Chiesa, Cecilia Simonelli, Giovanni Lo Re, Arvin Lheshi, Spazzapan Simon, Rodolfo Mattioli, Caterina Caminiti, Giancarlo Mazza, Maddalena Donini, Rodolfo Passalacqua

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dose-finding trial of a combined regsimen with bevacizumab, immunotherapy, and chemotherapy in patients with metastatic renal cell cancer: An italian oncology group for clinical research (GOIRC) study'. Together they form a unique fingerprint.

Medicine & Life Sciences